Evidence map›Paper›PMID 40624527›Full record

ReviewBMC musculoskeletal disorders2025

Early diagnosis and treatment of low-grade myofibroblastic sarcoma in the left distal femur: a case report and literature review.

Xinyu Hu, Yichen Gong, Zhongyi Zhang, Zhipeng Wu, Peijian Tong, Yan Liu, Shuaijie Lv

Abstract readCase ReportsReview
In one paragraph

Review in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xinyu Hu *Department of Orthopedics and Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine),, 54 Youdian Road, Hangzhou, Zhejiang Province, 310053, China.ORCID http://orcid.org/0009-0006-1661-5183
Yichen Gong *Department of Orthopedics and Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine),, 54 Youdian Road, Hangzhou, Zhejiang Province, 310053, China.
Zhongyi ZhangDepartment of Orthopedics and Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine),, 54 Youdian Road, Hangzhou, Zhejiang Province, 310053, China.
Zhipeng WuDepartment of Orthopedics and Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine),, 54 Youdian Road, Hangzhou, Zhejiang Province, 310053, China.
Peijian TongDepartment of Orthopedics and Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine),, 54 Youdian Road, Hangzhou, Zhejiang Province, 310053, China.
Yan LiuDepartment of Orthopedics and Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine),, 54 Youdian Road, Hangzhou, Zhejiang Province, 310053, China.
Shuaijie LvDepartment of Orthopedics and Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine),, 54 Youdian Road, Hangzhou, Zhejiang Province, 310053, China. lvshuaijie1990@126.com.

Funding

Zhejiang Province Traditional Chinese Medicine Science and Technology Program 2024ZL044
6 · The paper itself

Abstract

backgroundLow-grade myofibroblastic sarcoma (LGMS) is a rare malignant tumor with a predilection for soft tissue and bone. This is a rare malignant tumor with diagnostic challenges, often leading to misdiagnosis as other similar diseases. As a result, its exact incidence remains unclear. While pathologic studies have been reported, systematic clinical, radiological, and therapeutic evaluations remain limited.

methodsThis study presented a case of LGMS located in the left distal femur treated with distal femoral resection and total knee arthroplasty using a tumor knee joint system. A review of 24 published cases was conducted for comparative analysis, focusing on clinical presentations, radiological features, immunohistochemical findings, treatment strategies, and long-term outcomes.

resultsRadiological analysis revealed a tumor confined to the distal femoral medullary cavity without cortical destruction or lytic changes. Immunohistochemical staining demonstrated: SMA (+), p53 (+), Ki-67 (30% +), CD163 (+), and CD68 (+), confirming the diagnosis of LGMS. Postoperatively, the patient reported significant pain relief and functional recovery at five months, with VAS, WOMAC, and HSS scores indicating improved joint function. The literature review highlighted LGMS's predilection for local recurrence, emphasizing the importance of early diagnosis and surgical intervention.

conclusionLGMS demonstrates unique radiological and pathological features depending on its site of origin. Our case underscores the utility of wide excision and TKA in managing bone-involved LGMS. Further studies are needed to evaluate long-term outcomes and optimize management strategies.

Indexed as

Early Detection of CancerFemoral NeoplasmsFemurMyosarcomaSarcomaArthroplasty, Replacement, KneeHumansNeoplasm GradingTreatment OutcomeEarly diagnosisImmunohistochemistryLow-grade myofibroblastic sarcomaTotal knee arthroplastyTumor knee joint system

Identifiers

PMID40624527
PMCPMC12235869

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.